[1]
Kunecki, M. et al. 2022. Levosimendan protects against ischemia – reperfusion injury in the human heart muscle. A pilot study. Current Issues in Pharmacy and Medical Sciences. 35, 4 (Dec. 2022), 219–223. DOI:https://doi.org/10.2478/cipms-2022-0038.